AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29680656
Drug: Mulberry leaf
RxNorm normalized name: MULBERRY
DrugBank: Broussonetia papyrifera pollen (DB10736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mulberry leaf flavonoids added at 3 g/calf per day (MLF)
Trial: 20456336
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg/week
Trial: 10730559
Drug: Mesalazine enema
RxNorm normalized name: mesalamine Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine enema (2 g/60 ml twice a day)
Trial: 6165750
Drug: Chamber A
RxNorm normalized name: Dual Chamber Automix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamber A (1000 PNU/ml ragweed extract)
Trial: 6165750
Drug: Chamber C
RxNorm normalized name: Flexichamber Child Mask (Large)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamber C (1000 PNU/ml ragweed and 50 ng histamine)
Trial: 30177585
Drug: Pemetrexed monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed monotherapy (P)
Trial: 26742388
Drug: Non-restricted medication
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-restricted medication
Trial: 18430685
Drug: Targeted implanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted implanted cortical electrical stimulation of the motor cortex with upper limb rehabilitation therapy
Trial: 17201251
Drug: Aildenafil citrate
RxNorm normalized name: Sildenafil Citrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aildenafil citrate 30 or 60 mg
Trial: 12562652
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics (ciprofloxacin and roxithromycin)
Trial: 19947900
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg once daily
Trial: 30304457
Drug: 8% micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% micronized vaginal progesterone (MVP) gel 90 mg daily
Trial: 28265691
Drug: BMS-986142 (5-900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-986142 (5-900 mg single dose; 25-350 mg multiple doses, once daily for 14 days)
Trial: 28265691
Drug: BMS-986142 (350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-986142 (350 mg, once daily for 5 days)
Trial: 16308253
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (200 microg/day) for 3 months
Trial: 8819498
Drug: Buprenorphine maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine maintenance (8 mg/day with p.o. placebo)
Trial: 8819498
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance (80 mg/day)
Trial: 3864038
Drug: Hyperimmune hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperimmune hepatitis B immunoglobulin (HBIg) administered at birth and six weeks
Trial: 29037773
Drug: S+NAC500 (simethicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S+NAC500 (simethicone 200 mg + N-acetylcysteine 500 mg)
Trial: 29037773
Drug: S+NAC1000 (simethicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S+NAC1000 (simethicone 200 mg + N-acetylcysteine 1000 mg)
Trial: 29037773
Drug: S (simethicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S (simethicone 200 mg)
Trial: 29037773
Drug: Water (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (100 mL)
Trial: 16024862
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (10 mg/kg intravenously before and after surgery, continued orally for 4 days at 20 mg/kg/8 hours)
Trial: 29249583
Drug: Bronchial blocker
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchial blocker (BB)
Trial: 24231197
Drug: Bronchial blocker
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchial blocker with disconnection technique (BB with disconnection)
Trial: 20683173
Drug: Orlistat plus
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat plus L-carnitine (orlistat 120 mg three times a day plus L-carnitine 2 g one time a day)
Trial: 20683173
Drug: Orlistat (orlistat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat (orlistat 120 mg three times a day)
Trial: 12594639
Drug: Saline injections
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injections (placebo)
Trial: 7986714
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy with blood progenitor transplantation (priming regimen: cyclophosphamide 3 g/m2, etoposide 900 mg/m2 with GM-CSF; high-dose chemotherapy: thiotepa 750 mg/m2, busulfan 10 mg/kg, cyclophosphamide 120 mg/kg)
Trial: 7986714
Drug: Control patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control patients who did not receive intensive treatment
Trial: 5090761
Drug: Slow-K (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-K (32 mEq daily)
Trial: 5090761
Drug: Triamterene (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triamterene (50 mg twice daily)
Trial: 26687696
Drug: Alirocumab 75
RxNorm normalized name: alirocumab 75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75 mg SC every 2 weeks (Q2W)
Trial: 26687696
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg/d (rechallenge)
Trial: 18088263
Drug: Community nurse
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community nurse visits before discharge, within seven days of discharge, weekly for four weeks, then monthly.
Trial: 10802159
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin injection therapy (CIT)
Trial: 7684080
Drug: Seven pediculicidal
RxNorm normalized name: Sevenfact
DrugBank: Coagulation factor VIIa Recombinant Human (DB00036)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seven pediculicidal agents with their supplied nit removal combs
Trial: 2949059
Drug: SKF 38393
RxNorm normalized name: SKF-96365 free base
DrugBank: SKF-96365 free base (DB17054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SKF 38393 (selective D‐1 dopamine receptor agonist)
Trial: 2949059
Drug: SKF 38393
RxNorm normalized name: SKF-96365 free base
DrugBank: SKF-96365 free base (DB17054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SKF 38393 combined with intravenous levodopa
Trial: 25614126
Drug: Plant sterols
RxNorm normalized name: Plant Sterols/Stanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterols (2 g)
Trial: 23549137
Drug: Tonic treatment.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tonic treatment.
Trial: 9433370
Drug: Fexofenadine HCl
RxNorm normalized name: fexofenadine HCl
DrugBank: Fexofenadine (DB00950)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexofenadine HCl 120 mg
Trial: 16119039
Drug: Fexofenadine HCl
RxNorm normalized name: fexofenadine HCl
DrugBank: Fexofenadine (DB00950)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexofenadine HCl 180 mg
Trial: 2004528
Drug: Eutectic combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eutectic combination of EE:CHOL (50 mg of mixture providing 0.050 mg of ethinylestradiol)
Trial: 2004528
Drug: 50 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 micrograms tablet of ethinylestradiol (Dianor, Syntex)
Trial: 2004528
Drug: Eutectic combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eutectic combination of EE:CHOL
Trial: 7047686
Drug: Azathioprine therapy
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine therapy (2 mg/kg/day)
Trial: 31543215
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) as a periprocedural bridging anticoagulant
Trial: 29936918
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (1.25 mg vitamin D3 monthly for 24 months)
Trial: 25102730
Drug: Cytoflavin administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cytoflavin administration combined with standard therapy
Trial: 24948702
Drug: Empirical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical treatment
Trial: 11789242
Drug: Salvia injection
RxNorm normalized name: SALVIA OFFICINALIS
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvia injection and Di'ao Xinxuekang (Control)
Trial: 29025406
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg/die
Trial: 24029022
Drug: Ultrasound-guided combined
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided combined sciatic-femoral nerve block (USFB) with a 25 ml mixture (10 ml of 2.0% lidocaine, 10 ml of 0.5% levobupivacaine, and 5 ml of saline)
Trial: 24029022
Drug: Unilateral spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral spinal anaesthesia (USA) with 2 ml (10 mg) of 0.5% levobupivacaine
Trial: 19349078
Drug: Clomipramine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (mean dose 125 mg daily)
Trial: 16700824
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (27.9±14.8 mg/kg/24 hr)
Trial: 8384388
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (Fragmin) 5,000 IU subcutaneously once daily for six days, starting preoperatively
Trial: 27128496
Drug: Oxycodone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (1 mg/mL)
Trial: 12884545
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (500 mg daily in pellets for 8 to 12 hours)
Trial: 10871560
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g oat bran concentrate (OBC; containing 3 g beta-glucan)
Trial: 10871560
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g wheat bran (control)
Trial: 22508711
Drug: Candesartan (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (32 mg)
Trial: 18846777
Drug: Nitrendipine 20
RxNorm normalized name: nitrendipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 20 mg (single dose)
Trial: 7555212
Drug: Best guess
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best guess combined antibiotic therapy (group COMB)
Trial: 7555212
Drug: Open group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open group with free combination of antibiotics (group OPEN)
Trial: 7072624
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg iron once daily
Trial: 7072624
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg iron 3 times daily
Trial: 29051325
Drug: Intravitreal aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal aflibercept 2 mg every 4 weeks (2q4)
Trial: 31917731
Drug: Intravitreal aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal aflibercept 2 mg every 12 weeks (2q12)
Trial: 26731792
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1000 mg)
Trial: 9693241
Drug: Piritramide (0.1‐0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piritramide (0.1‐0.3 mg/kg) and midazolam (1‐3 mg) i.v.
Trial: 9693241
Drug: Lidocaine/prilocaine cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine/prilocaine cream (30 g) topically and diclofenac suppository (100 mg)
Trial: 7662079
Drug: Cefcanel 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefcanel 300 mg tablets twice daily
Trial: 7662079
Drug: Cefaclor 250
RxNorm normalized name: cefaclor 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor 250 mg capsules three times daily
Trial: 2547256
Drug: Prophylactic anti-CMV
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic anti-CMV immunoglobulin administration
Trial: 27669664
Drug: Chewed oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewed oxycodone DETERx
Trial: 27669664
Drug: Intact oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact oxycodone DETERx
Trial: 2828412
Drug: 1,25-dihydroxyvitamin D
RxNorm normalized name: 1,25-dihydroxyvitamin D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-dihydroxyvitamin D (0.5 micrograms daily)
Trial: 26563011
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication (Control)
Trial: 11801931
Drug: Dexamethasone (0.15-1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.15-1.0 mg/kg; maximum dose 8-25 mg)
Trial: 7694306
Drug: haloperidol 2‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol 2‐20 mg daily
Trial: 3123607
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of levodopa with deprenyl
Trial: 18266548
Drug: Caffeine-containing supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine-containing supplement (200 mg)
Trial: 10890612
Drug: Gastric (G)
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric (G) feeding
Trial: 30672178
Drug: Needle-knife therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle-knife therapy combined with moxa stick pressure moxibustion
Trial: 23822942
Drug: Endovenous laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovenous laser ablation (EVLA) with concurrent phlebectomies
Trial: 18647300
Drug: Dapoxetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapoxetine (30 mg and 60 mg combined)
Trial: 3520177
Drug: Computerized feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerized feedback on prescription charges
Trial: 22536592
Drug: Lycopene gel
DrugBank: Lycopene (DB11231)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lycopene gel
Trial: 19886920
Drug: Grass allergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass allergy immunotherapy tablet (AIT) - Graza (Phleum pratense 75,000 SQ‐T/2800 BAU; ALK, Denmark) for 3 years followed by 1 year follow-up
Trial: 19886920
Drug: Grass allergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass allergy immunotherapy tablet (AIT) - Graza
Trial: 12951650
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (60 IU, once daily)
Trial: 8964890
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg DEX daily
Trial: 3924981
Drug: Pseudomonic acid
RxNorm normalized name: Pseudomonic acid
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pseudomonic acid cream applied three times a day for 5 days
Trial: 28264725
Drug: Extracorporeal shockwave
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shockwave therapy (ESWT) using PiezoWave 2 shockwave system, administered three times per week for 3 weeks.
Trial: 28264725
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment to the calf muscle bulk, administered three times per week for 3 weeks.
Trial: 25243340
Drug: EP-101 (12.5-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EP-101 (12.5-400 μg)
Trial: 12545257
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg morphine sulfate
Trial: 12545257
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml 0.25% ropivacaine
Trial: 12545257
Drug: Physiological NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological NaCl solution (placebo)
Trial: 9506001
Drug: Azelastine HCl
RxNorm normalized name: azelastine HCl
DrugBank: Azelastine (DB00972)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Azelastine HCl (4.4 mg every 12 hrs)
Trial: 9506001
Drug: Azelastine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine with ketoconazole (200 mg every 12 hrs)
Trial: 8476215
Drug: OK-432 intracutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 intracutaneous injection
Trial: 30126672
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg) + Desmopressin (40 micrograms, 4 puffs)
Trial: 30126672
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg) + Placebo
Trial: 23290819
Drug: PPM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPM plus cisplatin (230 mg/m(2) + 60 mg/m(2))
Trial: 26113503
Drug: 0.2 μg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 μg/day fluocinolone acetonide (FAc) implant in cataract after implant (CAI) group
Trial: 21113799
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of co-morbid drug abuse
Trial: 12728089
Drug: Amoxicillin‐clavulanate (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin‐clavulanate (45 mg/kg/d) for 7 days
Trial: 8976822
Drug: Carboplatin 500
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 500 mg/m2
Trial: 1546776
Drug: AIDS education
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIDS education with optional HIV antibody testing
Trial: 25306750
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg/day in combination with metformin 2 g/day
Trial: 25306750
Drug: Metformin 1.5-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1.5-2 g/day
Trial: 15805377
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline solution) administered intravenously before oral administration of glucose
Trial: 11207036
Drug: OK-432 intratumoral
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: OK-432 intratumoral injection (10 KE) before surgery
Trial: 11207036
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no OK-432 injection)
Trial: 9562618
Drug: Heparin during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin during hemodialysis
Trial: 30502851
Drug: Ferric Carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric Carboxymaltose (FCM) - 1000mg IV infusion over 15 minutes
Trial: 30502851
Drug: Oral Ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Ferrous Sulphate - 325mg daily until delivery
Trial: 27513339
Drug: Protandim® (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protandim® (1 pill a day for 90 days)
Trial: 29618599
Drug: Atorvastatin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (both doses)
Trial: 20051130
Drug: Sertraline (SRT)
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline (SRT)
Trial: 15943653
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of CBT and SRT (COMBINED)
Trial: 15866398
Drug: Topical betamethasone
RxNorm normalized name: betamethasone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical betamethasone 0.1% cream
Trial: 11956506
Drug: SB 249417
RxNorm normalized name: SB 224289
DrugBank: SB 224289 (DB17052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB 249417 (humanized anti-factor IX antibody)
Trial: 9457933
Drug: Transdermal E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal E2 (100 microg/d)
Trial: 7620000
Drug: Intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immune globulin (IVIG; 750 mg/kg)
Trial: 6370028
Drug: Flunitrazepam (1-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (1-2 mg)
Trial: 31148979
Drug: 20IU of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20IU of oxytocin infusion